KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Other Accumulated Expenses (2016 - 2025)

Fulgent Genetics' Other Accumulated Expenses history spans 7 years, with the latest figure at $2.8 million for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses fell 39.87% year-over-year to $2.8 million; the TTM value through Dec 2025 reached $2.8 million, down 39.87%, while the annual FY2025 figure was $2.8 million, 39.87% down from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $2.8 million at Fulgent Genetics, down from $5.0 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $12.6 million in Q1 2021 and bottomed at $281000.0 in Q3 2023.
  • The 5-year median for Other Accumulated Expenses is $2.8 million (2025), against an average of $3.2 million.
  • The largest annual shift saw Other Accumulated Expenses skyrocketed 729.27% in 2021 before it plummeted 91.33% in 2022.
  • A 5-year view of Other Accumulated Expenses shows it stood at $680000.0 in 2021, then skyrocketed by 213.82% to $2.1 million in 2022, then surged by 97.52% to $4.2 million in 2023, then grew by 12.34% to $4.7 million in 2024, then tumbled by 39.87% to $2.8 million in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Other Accumulated Expenses are $2.8 million (Q4 2025), $5.0 million (Q2 2025), and $4.7 million (Q4 2024).